Outsourced Pharma App Notes & Case Studies
-
Vials Vs. Cryobags For Cryopreservation Of Therapeutically Relevant T Cells
7/20/2023
Explore how COP 50 mL vials could serve as a basis for cell therapies and storage solution to help facilitate the manufacture and commercialization of cell products.
-
Raman As A Quality Control Tool For Cell Culture Media Preparation
6/14/2024
Explore study results demonstrating how Raman technology easily differentiates between media with similar compositions and detects potential preparation errors that other analysis methods might miss.
-
Review Of Applications And Processes In Fixed-Bed Bioreactors
5/6/2024
Gain insights and guidelines for developing new processes in this review evaluating publications on the applications of single-use, scalable fixed-bed bioreactors for adherent cell culture processes.
-
QC Lab Program And Project Management
12/20/2023
A client aimed to consolidate quality control laboratory operations into a singular facility and operate as one organization. Gain insight into the services that helped deliver the project on schedule.
-
Reducing Risk And Timelines In Cell Line Development
3/25/2025
Accelerate your biologic development by adopting faster, more reliable clone selection methods that reduce time and resources while improving the likelihood of identifying stable, high-producing cell lines.
-
Seizing Market Share Pre-Patent Expiry: The Evolution Of A CDMO Partnership In Navigating A Paragraph IV ANDA Submission
6/26/2024
The dynamic pharmaceutical landscape demands agility and strategic foresight. Explore how leveraging a key partnership helped to overcome a looming patent expiry for a second-generation acne medication.
-
Trends In Next-Generation Delivery Technologies
11/22/2023
Learn how lipid nanoparticles are enabling a new generation of engineered cell therapies with a push toward more complex cell engineering and gene editing for allogeneic therapies.
-
Reducing The Level Of Host Cell Proteins In The Bioreactor Harvest
10/20/2023
Learn how MilliporeSigma helped a customer drastically reduce the level of HCPs in the bioreactor harvest prior to a production run to supply drug substance for a scheduled Phase 1 clinical trial.
-
Residence Time Of Powders In Tablet Compression
7/30/2024
Knowing how formulation moves through a tablet process is invaluable in optimizing the process for the greatest tablet quality and production.
-
Standardizing Cryopreservation For Cell Therapy Supply Chains
6/3/2025
Explore how a standardized cryopreservation process is transforming leukapheresis handling by reducing risk and improving quality across the cell therapy supply chain.